Literature DB >> 18307375

The nature of the relationship between attention-deficit/hyperactivity disorder and substance use.

Timothy E Wilens1.   

Abstract

This report examines the developmental relationship between attention-deficit/hyperactivity disorder (ADHD) and substance use disorders (SUD) and associated concurrent disorders relative to adolescents and adults. ADHD is a risk factor for the development of SUD in adulthood, and it is particularly of concern with conduct and bipolar disorder comorbidities. Conversely, approximately one fifth of adults with SUD have ADHD. Individuals with SUD and ADHD have a more severe and complicated course of SUD. Pharmacotherapeutic treatment of ADHD in children reduces the risk for later cigarette smoking and SUD in adulthood.

Entities:  

Mesh:

Year:  2007        PMID: 18307375

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  33 in total

1.  Attention deficit hyperactivity symptoms and risky sexual behavior in young adult women.

Authors:  G M Monawar Hosain; Abbey B Berenson; Howard Tennen; Lance O Bauer; Z Helen Wu
Journal:  J Womens Health (Larchmt)       Date:  2012-02-03       Impact factor: 2.681

2.  Impact of ADHD and cannabis use on executive functioning in young adults.

Authors:  Leanne Tamm; Jeffery N Epstein; Krista M Lisdahl; Brooke Molina; Susan Tapert; Stephen P Hinshaw; L Eugene Arnold; Katerina Velanova; Howard Abikoff; James M Swanson
Journal:  Drug Alcohol Depend       Date:  2013-08-11       Impact factor: 4.492

3.  Adult outcomes of childhood dysregulation: a 14-year follow-up study.

Authors:  Robert R Althoff; Frank C Verhulst; David C Rettew; James J Hudziak; Jan van der Ende
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2010-11       Impact factor: 8.829

4.  ADHD symptoms, autistic traits, and substance use and misuse in adult Australian twins.

Authors:  Duneesha De Alwis; Arpana Agrawal; Angela M Reiersen; John N Constantino; Anjali Henders; Nicholas G Martin; Michael T Lynskey
Journal:  J Stud Alcohol Drugs       Date:  2014-03       Impact factor: 2.582

Review 5.  The limbic-hypothalamic-pituitary-adrenal axis and the development of alcohol use disorders in youth.

Authors:  Ty S Schepis; Uma Rao; Hardik Yadav; Bryon Adinoff
Journal:  Alcohol Clin Exp Res       Date:  2011-01-11       Impact factor: 3.455

6.  The 10th Anniversary of the Eli Lilly Chair of Schizophrenia from the University of Montreal.

Authors:  Emmanuel Stip; Stéphane Potvin
Journal:  Can J Psychiatry       Date:  2015-03       Impact factor: 4.356

7.  Prospective relationships of ADHD symptoms with developing substance use in a population-derived sample.

Authors:  E Sihvola; R J Rose; D M Dick; T Korhonen; L Pulkkinen; A Raevuori; M Marttunen; J Kaprio
Journal:  Psychol Med       Date:  2011-05-20       Impact factor: 7.723

8.  SNPs in dopamine D2 receptor gene (DRD2) and norepinephrine transporter gene (NET) are associated with continuous performance task (CPT) phenotypes in ADHD children and their families.

Authors:  S H Kollins; A D Anastopoulos; A M Lachiewicz; D FitzGerald; E Morrissey-Kane; M E Garrett; S L Keatts; A E Ashley-Koch
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-12-05       Impact factor: 3.568

Review 9.  European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD.

Authors:  Sandra J J Kooij; Susanne Bejerot; Andrew Blackwell; Herve Caci; Miquel Casas-Brugué; Pieter J Carpentier; Dan Edvinsson; John Fayyad; Karin Foeken; Michael Fitzgerald; Veronique Gaillac; Ylva Ginsberg; Chantal Henry; Johanna Krause; Michael B Lensing; Iris Manor; Helmut Niederhofer; Carlos Nunes-Filipe; Martin D Ohlmeier; Pierre Oswald; Stefano Pallanti; Artemios Pehlivanidis; Josep A Ramos-Quiroga; Maria Rastam; Doris Ryffel-Rawak; Steven Stes; Philip Asherson
Journal:  BMC Psychiatry       Date:  2010-09-03       Impact factor: 3.630

10.  Medial temporal lobe functioning and structure in the spontaneously hypertensive rat: comparison with Wistar-Kyoto normotensive and Wistar-Kyoto hypertensive strains.

Authors:  Audrey M Wells; Amy C Janes; Xiaoxu Liu; Christian F Deschepper; Marc J Kaufman; Kathleen M Kantak
Journal:  Hippocampus       Date:  2010-06       Impact factor: 3.899

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.